Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence

被引：0
|
作者：
Davide Campana
Gabriele Capurso
Stefano Partelli
Francesca Nori
Francesco Panzuto
Domenico Tamburrino
Giulia Cacciari
Gianfranco Delle Fave
Massimo Falconi
Paola Tomassetti
机构：
[1] University of Bologna,Department of Medical and Surgical Sciences, S. Orsola
[2] “Sapienza” University of Rome,Malpighi Hospital
[3] Sacro Cuore Don Calabria Hospital,Digestive and Liver Disease Unit
[4] University of Verona,Department of Surgery
[5] Università Politecnica delle Marche,Department of Surgery
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2013年 / 40卷
关键词：
Lu-DOTATATE; Y-DOTATOC; Neuroendocrine tumours; Radiotherapy; Somatostatin receptors; Therapeutic chemoembolization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1197 / 1205
页数：8
相关论文
共 43 条
  • [1] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Campana, Davide
    Capurso, Gabriele
    Partelli, Stefano
    Nori, Francesca
    Panzuto, Francesco
    Tamburrino, Domenico
    Cacciari, Giulia
    Delle Fave, Gianfranco
    Falconi, Massimo
    Tomassetti, Paola
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (08) : 1197 - 1205
  • [2] Comment on Campana et al.: Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Ezziddin, Samer
    Sabet, Amir
    Yong-Hing, Charlotte Jane
    Biersack, Hans-Juergen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) : 174 - 175
  • [3] Comment on Campana et al.: Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Samer Ezziddin
    Amir Sabet
    Charlotte Jane Yong-Hing
    Hans-Jürgen Biersack
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 174 - 175
  • [4] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al.
    Campana, Davide
    Delle Fave, Gianfranco
    Falconi, Massimo
    Tommassetti, Paola
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) : 176 - 177
  • [5] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al.
    Davide Campana
    Gianfranco Delle Fave
    Massimo Falconi
    Paola Tommassetti
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 176 - 177
  • [6] Somatostatin analogue treatment of neuroendocrine tumours
    deHerder, WW
    vanderLely, AJ
    Lamberts, SWJ
    POSTGRADUATE MEDICAL JOURNAL, 1996, 72 (849) : 403 - 408
  • [7] Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues
    Kaltsas, GA
    Papadogias, D
    Makras, P
    Grossman, AB
    ENDOCRINE-RELATED CANCER, 2005, 12 (04) : 683 - 699
  • [8] Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues
    Van Eijck, CHJ
    BRITISH JOURNAL OF SURGERY, 2005, 92 (11) : 1333 - 1334
  • [9] Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
    Modlin, I. M.
    Pavel, M.
    Kidd, M.
    Gustafsson, B. I.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (02) : 169 - 188
  • [10] Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours
    F. Forrer
    J. Mueller-Brand
    H. Maecke
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 (4) : 511 - 512
12345